26th Mar 2025 10:00
Dr. Martens plc (the "Company")
Director/PDMR Shareholding
Notification of Transaction by Director/Person Discharging Managerial Responsibility
Dr. Martens plc (the "Company") announces that it has been notified of the following transaction in the Company's Ordinary 1p shares undertaken on behalf of a director and person discharging managerial responsibility ("PDMR").
On 25 March 2025, Giles Wilson, Chief Financial Officer, received a cash payment pursuant to the buyout arrangements agreed in advance of his appointment in May 2024, details of which were disclosed in the Company's 2024 Annual Report. In line with the Company's Remuneration Policy, one third of the net amount payable was subsequently used to purchase shares which Giles is required to hold for a minimum of two years.
The relevant notification, set out below, is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Giles Wilson | ||||
2 | Reason for the notification | |||||
a) | Position/status | PDMR (Chief Financial Officer) | ||||
b) | Initial notification/Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Dr. Martens plc | ||||
b) | LEI | 213800QPT8YM6NQZPH28 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of GBP 0.01
ISIN: GB00BL6NGV24 | ||||
b) | Nature of the transaction | Purchase of Ordinary shares. | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
|
32,640 54.0083p
| ||||
e) | Date of the transaction | 25 March 2025 | ||||
f) | Place of the transaction | XLON | ||||
Related Shares:
Dr. Martens